Cardiac Ablation Devices - Medical Devices Pipeline Assessment, 2018

  • ID: 4580443
  • Report
  • 101 pages
  • GlobalData
1 of 4

FEATURED COMPANIES

  • Adagio Medical Inc.
  • AngioDynamics Inc
  • CPSI Biotech
  • Helical Solutions, Inc.
  • Kardium Inc
  • Northwestern University
  • MORE
Cardiac Ablation Devices - Medical Devices Pipeline Assessment, 2018

Summary

The Medical Devices sector report, “Cardiac Ablation Devices - Medical Devices Pipeline Assessment, 2018" provides an overview of Cardiac Ablation Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Cardiac Ablation Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by The team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Cardiac Ablation Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Cardiac Ablation Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Cardiac Ablation Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Adagio Medical Inc.
  • AngioDynamics Inc
  • CPSI Biotech
  • Helical Solutions, Inc.
  • Kardium Inc
  • Northwestern University
  • MORE
1 Table of Contents
1.1 List of Tables
1.2 List of Figures

2 Introduction
2.1 Cardiac Ablation Devices Overview

3 Products under Development
3.1 Cardiac Ablation Devices - Pipeline Products by Stage of Development
3.2 Cardiac Ablation Devices - Pipeline Products by Territory
3.3 Cardiac Ablation Devices - Pipeline Products by Regulatory Path
3.4 Cardiac Ablation Devices - Pipeline Products by Estimated Approval Date
3.5 Cardiac Ablation Devices - Ongoing Clinical Trials

4 Cardiac Ablation Devices - Pipeline Products under Development by Companies
4.1 Cardiac Ablation Devices Companies - Pipeline Products by Stage of Development
4.2 Cardiac Ablation Devices - Pipeline Products by Stage of Development

5 Cardiac Ablation Devices Companies and Product Overview
5.1 AblaCor Medical Corporation Company Overview
5.1.1 AblaCor Medical Corporation Pipeline Products & Ongoing Clinical Trials Overview
5.2 Adagio Medical Inc. Company Overview
5.2.1 Adagio Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.3 AFreeze GmbH Company Overview
5.3.1 AFreeze GmbH Pipeline Products & Ongoing Clinical Trials Overview
5.4 AngioDynamics Inc Company Overview
5.4.1 AngioDynamics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.5 AtriCure Inc Company Overview
5.5.1 AtriCure Inc Pipeline Products & Ongoing Clinical Trials Overview
5.6 CPSI Biotech Company Overview
5.6.1 CPSI Biotech Pipeline Products & Ongoing Clinical Trials Overview
5.7 Enigma Medical, Inc. Company Overview
5.7.1 Enigma Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.8 Helical Solutions, Inc. (Inactive) Company Overview
5.8.1 Helical Solutions, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.9 Johns Hopkins University Company Overview
5.9.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
5.10 Kardium Inc Company Overview
5.10.1 Kardium Inc Pipeline Products & Ongoing Clinical Trials Overview
5.11 LuxCath, LLC Company Overview
5.11.1 LuxCath, LLC Pipeline Products & Ongoing Clinical Trials Overview
5.12 Northwestern University Company Overview
5.12.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview
5.13 Sheba Medical Center Company Overview
5.13.1 Sheba Medical Center Pipeline Products & Ongoing Clinical Trials Overview
5.14 Spectranetics Corp Company Overview
5.14.1 Spectranetics Corp Pipeline Products & Ongoing Clinical Trials Overview
5.15 Thermedical Inc Company Overview
5.15.1 Thermedical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.16 Tufts Medical Center Company Overview
5.16.1 Tufts Medical Center Pipeline Products & Ongoing Clinical Trials Overview
5.17 University of California Los Angeles Company Overview
5.17.1 University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview
5.18 University of Chicago Company Overview
5.18.1 University of Chicago Pipeline Products & Ongoing Clinical Trials Overview
5.19 VytronUS, Inc. Company Overview
5.19.1 VytronUS, Inc. Pipeline Products & Ongoing Clinical Trials Overview

6 Cardiac Ablation Devices- Recent Developments
6.1 May 24, 2018: Medtronic Reports Fourth Quarter And Fiscal Year 2018 Financial Results
6.2 May 07, 2018: Medtronic Appoints Mike Weinstein As Senior Vice President Of Strategy
6.3 Apr 26, 2018: AtriCure Reports First Quarter 2018 Financial Results
6.4 Apr 25, 2018: Boston Scientific Reports Financial Results For First Quarter 2018
6.5 Apr 05, 2018: Dr. Laura Mauri to Join Medtronic as Vice President, Global Clinical Research & Analytics
6.6 Mar 29, 2018: AngioDynamics Reports Fiscal 2018 Third Quarter Financial Results
6.7 Mar 28, 2018: Vascular Insights Announces New Chief Financial Officer
6.8 Mar 19, 2018: In vitro study details the increased performance and potential of CPSI’s Supercritical Nitrogen cryoablation device for the epicardial based ablation of cardiac tissue
6.9 Mar 16, 2018: Vascular Insights Announces A New Lead To The Global Commercial Team
6.10 Mar 08, 2018: Baylis Medical wins Best Managed Companies award
6.11 Mar 06, 2018: Stereotaxis Reports 2017 Fourth Quarter And Full Year Financial Results
6.12 Mar 05, 2018: USPTO allows AblaCor five ablation catheter-anchoring patents for its CircumBlator AF Catheter Ablation System
6.13 Mar 05, 2018: AblaCor Appoints Lawrence Rosenthal To Its Scientific Advisory Board
6.14 Feb 26, 2018: AtriCure Announces Fourth Quarter and Full Year 2017 Financial Results
6.15 Feb 20, 2018: AtriCure Names Scott Drake Board Chairman
6.16 Feb 01, 2018: Boston Scientific Announces Results for Fourth Quarter and Full Year 2017
6.17 Jan 30, 2018: Alex Gu Named Senior Vice President and President of Medtronic's Greater China Region
6.18 Jan 25, 2018: Vascular Insights Announces New Chief Executive Officer
6.19 Jan 22, 2018: Baylis Medical embraces advanced manufacturing with opening of state-of-the-art lab
6.20 Jan 09, 2018: Boston Scientific Announces Preliminary Unaudited Sales For The Fourth Quarter And Full Year Ended December 31, 2017
6.21 Jan 08, 2018: AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2017
6.22 Jan 08, 2018: Stereotaxis Reports Preliminary Fourth Quarter 2017 Revenue Results
6.23 Jan 04, 2018: AngioDynamics Reports Fiscal 2018 Second Quarter Financial Results
6.24 Dec 19, 2017: Bob White Named Executive Vice President and President of Medtronic's Minimally Invasive Therapies Group; Chris Lee to Assume Leadership of Medtronic's Asia Pacific Region
6.25 Nov 21, 2017: Medtronic Reports Second Quarter Financial Results
6.26 Nov 09, 2017: Stereotaxis Reports Third Quarter 2017 Financial Results
6.27 Nov 08, 2017: Medtronic Announces Preliminary Second Quarter Revenue
6.28 Nov 02, 2017: Medtronic Releases Fiscal Year 2017 Integrated Performance Report
6.29 Nov 01, 2017: AtriCure Reports Third Quarter 2017 Financial Results
6.30 Oct 26, 2017: Boston Scientific Announces Results For Third Quarter 2017
6.31 Oct 25, 2017: Baylis Medical's Kris Shah appointed to AdvaMed Accel Board of Directors
6.32 Oct 06, 2017: Medtronic Provides Update on Impact from Hurricane Maria
6.33 Oct 04, 2017: Boston Scientific Appoints Desiree Ralls-Morrison General Counsel and Corporate Secretary
6.34 Sep 28, 2017: AngioDynamics Reports Fiscal 2018 First Quarter Results
6.35 Aug 23, 2017: Baylis Medical strengthens global expansion plans with senior hire
6.36 Aug 22, 2017: Medtronic Reports First Quarter Financial Results
6.37 Aug 10, 2017: Stereotaxis Reports Second Quarter 2017 Financial Results
6.38 Aug 03, 2017: Spectranetics Reports Second Quarter 2017 Revenue of $74.7 million
6.39 Aug 02, 2017: SAMHSA announces $6 million in grants to support the International President’s Emergency Plan for AIDS Relief Addiction Technology Transfer Centers
6.40 Jul 27, 2017: Boston Scientific Announces Results for Second Quarter 2017
6.41 Jul 27, 2017: AtriCure Reports Second Quarter 2017 Financial Results
6.42 Jul 18, 2017: AngioDynamics Reports Fiscal 2017 Fourth Quarter and Full-Year Results
6.43 Jul 18, 2017: AtriCure Announces Hiring of Chief Technology Officer
6.44 Jul 11, 2017: A study confirms epicardial ablation as an effective treatment of Brugada Syndrome in patients at risk of ventricular fibrillation
6.45 Jun 27, 2017: Boston Scientific Outlines Strategy for Sustained Growth at 2017 Investor Day
6.46 Jun 14, 2017: Spectranetics Announces Election of New Chairperson of the Board of Directors

7 Appendix
7.1 Methodology
7.2 About the Publisher
7.3 Contact Us
7.4 Disclaimer

List of Tables
Table 1: Cardiac Ablation Devices - Pipeline Products by Stage of Development
Table 2: Cardiac Ablation Devices - Pipeline Products by Territory
Table 3: Cardiac Ablation Devices - Pipeline Products by Regulatory Path
Table 4: Cardiac Ablation Devices - Pipeline Products by Estimated Approval Date
Table 5: Cardiac Ablation Devices - Ongoing Clinical Trials
Table 6: Cardiac Ablation Devices Companies - Pipeline Products by Stage of Development
Table 7: Cardiac Ablation Devices - Pipeline Products by Stage of Development
Table 8: AblaCor Medical Corporation Pipeline Products & Ongoing Clinical Trials Overview
Table 9: AutoBlator - Product Status
Table 10: AutoBlator - Product Description
Table 11: CircumBlator AF Catheter Ablation System - Product Status
Table 12: CircumBlator AF Catheter Ablation System - Product Description
Table 13: Adagio Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 14: PolarStar System - Product Status
Table 15: PolarStar System - Product Description
Table 16: Adagio Medical Inc. - Ongoing Clinical Trials Overview
Table 17: PolarStar System - A Prospective, Multicenter Investigation of the Adagio Cryoablation System in Patients with Atrial Fibrillation
Table 18: PolarStar System - A Prospective, Multicenter, Investigation of the Adagio PolarStar System in Subjects with Atrial Flutter
Table 19: AFreeze GmbH Pipeline Products & Ongoing Clinical Trials Overview
Table 20: CoolLoop - Product Status
Table 21: CoolLoop - Product Description
Table 22: Tip-Catheter - Product Status
Table 23: Tip-Catheter - Product Description
Table 24: AFreeze GmbH - Ongoing Clinical Trials Overview
Table 25: CoolLoop - CoolLoop Paroxysmal Atrial Fibrillation
Table 26: AngioDynamics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 27: Non-Thermal Vein Ablation Device - Product Status
Table 28: Non-Thermal Vein Ablation Device - Product Description
Table 29: AtriCure Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 30: AtriCure Bipolar System - Product Status
Table 31: AtriCure Bipolar System - Product Description
Table 32: AtriCure Inc - Ongoing Clinical Trials Overview
Table 33: AtriCure Bipolar System - Combined Endoscopic Epicardial and Percutaneous Endocardial Ablation Versus Repeated Catheter Ablation in Persistent and Longstanding Persistent Atrial Fibrillation
Table 34: CPSI Biotech Pipeline Products & Ongoing Clinical Trials Overview
Table 35: ICEolate Catheter - Product Status
Table 36: ICEolate Catheter - Product Description
Table 37: Enigma Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 38: Enigma Device - Product Status
Table 39: Enigma Device - Product Description
Table 40: Helical Solutions, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 41: Catheter-Based Ablation Device - Product Status
Table 42: Catheter-Based Ablation Device - Product Description
Table 43: Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
Table 44: Catheter Guiding Computational Modeling Tool - Product Status
Table 45: Catheter Guiding Computational Modeling Tool - Product Description
Table 46: Kardium Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 47: Globe Mapping And Ablation System - Product Status
Table 48: Globe Mapping And Ablation System - Product Description
Table 49: Kardium Inc - Ongoing Clinical Trials Overview
Table 50: Globe Mapping And Ablation System - A Prospective, Non-randomized Clinical Study to Assess Safety and Performance of a Device for Global Mapping and Ablation of the Left Atrium for the Treatment of Atrial Fibrillation
Table 51: LuxCath, LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 52: OmniView Light-Guided Ablation Catheter - Product Status
Table 53: OmniView Light-Guided Ablation Catheter - Product Description
Table 54: Northwestern University Pipeline Products & Ongoing Clinical Trials Overview
Table 55: Cardiac Tissue Ablation Device - Product Status
Table 56: Cardiac Tissue Ablation Device - Product Description
Table 57: Sheba Medical Center Pipeline Products & Ongoing Clinical Trials Overview
Table 58: Transcatheter Septal Myectomy Device - Product Status
Table 59: Transcatheter Septal Myectomy Device - Product Description
Table 60: Spectranetics Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 61: Nexcimer - Product Status
Table 62: Nexcimer - Product Description
Table 63: Thermedical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 64: Durablate Ablation Catheter - Product Status
Table 65: Durablate Ablation Catheter - Product Description
Table 66: SERF Ablation System - Ventricular Tachycardia - Product Status
Table 67: SERF Ablation System - Ventricular Tachycardia - Product Description
Table 68: Thermedical Inc - Ongoing Clinical Trials Overview
Table 69: SERF Ablation System - Ventricular Tachycardia - Saline-enhanced Radiofrequency (SERF) Catheter Ablation for the Treatment of Ventricular Tachycardia
Table 70: Durablate Ablation Catheter - Saline-enhanced Radiofrequency (SERF) Catheter Ablation for the Treatment of Ventricular Tachycardia
Table 71: Tufts Medical Center Pipeline Products & Ongoing Clinical Trials Overview
Table 72: Tissue Ablation Device - Product Status
Table 73: Tissue Ablation Device - Product Description
Table 74: University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview
Table 75: Cryogenic Anchor - Product Status
Table 76: Cryogenic Anchor - Product Description
Table 77: University of Chicago Pipeline Products & Ongoing Clinical Trials Overview
Table 78: DVT Histotripsy System - Product Status
Table 79: DVT Histotripsy System - Product Description
Table 80: VytronUS, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 81: Low-Intensity Collimated Ultrasound (LICU) Cardiac Mapping and Ablation System - Product Status
Table 82: Low-Intensity Collimated Ultrasound (LICU) Cardiac Mapping and Ablation System - Product Description
Table 83: VytronUS, Inc. - Ongoing Clinical Trials Overview
Table 84: Low-Intensity Collimated Ultrasound (LICU) Cardiac Mapping and Ablation System - Clinical Investigation of the VytronUS Ablation System for Treatment of Symptomatic Drug-refractory Paroxysmal Atrial Fibrillation
Table 85: Glossary

List of Figures
Figure 1: Cardiac Ablation Devices - Pipeline Products by Stage of Development
Figure 2: Cardiac Ablation Devices - Pipeline Products by Territory
Figure 3: Cardiac Ablation Devices - Pipeline Products by Regulatory Path
Figure 4: Cardiac Ablation Devices - Pipeline Products by Estimated Approval Date
Figure 5: Cardiac Ablation Devices - Ongoing Clinical Trials
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • AblaCor Medical Corporation
  • Adagio Medical Inc.
  • AFreeze GmbH
  • AngioDynamics Inc
  • AtriCure Inc
  • CPSI Biotech
  • Enigma Medical, Inc.
  • Helical Solutions, Inc.
  • Johns Hopkins University
  • Kardium Inc
  • LuxCath, LLC
  • Northwestern University
  • Sheba Medical Center
  • Spectranetics Corp
  • Thermedical Inc
  • Tufts Medical Center
  • University of California Los Angeles
  • University of Chicago
  • VytronUS, Inc.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll